Marshall Wace’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21M | Buy |
112,244
+107,281
| +2,162% | +$19.7M | 0.02% | 711 |
|
|
2026
Q1 | $937K | Buy |
+4,963
| New | +$1.05M | ﹤0.01% | 2167 |
|
|
2025
Q4 | – | Sell |
-444,564
| Closed | -$90.3M | – | 3477 |
|
|
2025
Q3 | $90.3M | Buy |
444,564
+5,529
| +1% | +$981K | 0.09% | 189 |
|
|
2025
Q2 | $77.3M | Buy |
439,035
+245,536
| +127% | +$37M | 0.09% | 219 |
|
|
2025
Q1 | $26M | Sell |
193,499
-306,056
| -61% | -$40.3M | 0.03% | 442 |
|
|
2024
Q4 | $63.1M | Sell |
499,555
-240,453
| -32% | -$35.8M | 0.08% | 242 |
|
|
2024
Q3 | $123M | Buy |
740,008
+26,029
| +4% | +$3.94M | 0.15% | 114 |
|
|
2024
Q2 | $95M | Buy |
713,979
+48,626
| +7% | +$5.85M | 0.13% | 150 |
|
|
2024
Q1 | $69.9M | Buy |
665,353
+16,515
| +3% | +$1.48M | 0.11% | 183 |
|
|
2023
Q4 | $49M | Sell |
648,838
-778,030
| -55% | -$49.3M | 0.08% | 239 |
|
|
2023
Q3 | $94M | Sell |
1,426,868
-854,597
| -37% | -$63.9M | 0.19% | 104 |
|
|
2023
Q2 | $186M | Buy |
2,281,465
+1,646,137
| +259% | +$117M | 0.36% | 48 |
|
|
2023
Q1 | $37.8M | Buy |
635,328
+443,715
| +232% | +$24.7M | 0.08% | 278 |
|
|
2022
Q4 | $9.35M | Buy |
191,613
+52,658
| +38% | +$2.43M | 0.02% | 843 |
|
|
2022
Q3 | $7.17M | Buy |
138,955
+107,265
| +338% | +$6.37M | 0.02% | 1124 |
|
|
2022
Q2 | $1.67M | Buy |
31,690
+3,637
| +13% | +$253K | ﹤0.01% | 2120 |
|
|
2022
Q1 | $2.41M | Sell |
28,053
-192,722
| -87% | -$15.8M | ﹤0.01% | 1940 |
|
|
2021
Q4 | $18M | Buy |
+220,775
| New | +$16.1M | 0.03% | 532 |
|
|
2021
Q2 | – | Sell |
-102,103
| Closed | -$5.31M | – | 3087 |
|
|
2021
Q1 | $5.31M | Buy |
102,103
+68,578
| +205% | +$3.47M | 0.02% | 800 |
|
|
2020
Q4 | $1.34M | Buy |
+33,525
| New | +$1.08M | 0.01% | 1094 |
|
|
2019
Q4 | – | Sell |
-3,800
| Closed | -$84K | – | 2058 |
|
|
2019
Q3 | $84K | Sell |
3,800
-186,783
| -98% | -$3.98M | ﹤0.01% | 1415 |
|
|
2019
Q2 | $3.94M | Sell |
190,583
-7,359
| -4% | -$170K | 0.03% | 563 |
|
|
2019
Q1 | $5.71M | Sell |
197,942
-51,210
| -21% | -$1.26M | 0.05% | 432 |
|
|
2018
Q4 | $4.27M | Buy |
+249,152
| New | +$6.03M | 0.04% | 494 |
|
|
2016
Q4 | – | Sell |
-60,518
| Closed | -$1.37M | – | 1115 |
|
|
2016
Q3 | $1.37M | Buy |
+60,518
| New | +$1.58M | 0.01% | 674 |
|
|
2015
Q3 | – | Sell |
-140,180
| Closed | -$8.11M | – | 1057 |
|
|
2015
Q2 | $8.11M | Buy |
+140,180
| New | +$7.16M | 0.11% | 213 |
|
Other funds holding THC
GCM
Marshall Wace's THC Position: Q2 2026 in Review
Marshall Wace increased its Tenet Healthcare (THC) stake by 2,162% in Q2 2026, buying an estimated $19.7M and bringing the position to 112,244 shares worth $21M. The position accounts for 0.02% of the portfolio, ranked #711.
Marshall Wace first reported a position in THC in Q2 2015 and has held it in 26 quarters since. The position peaked at $186M in Q2 2023. 680 funds tracked by Wall St. Rank hold THC as of Q2 2026.
- Marshall Wace held 112,244 shares of Tenet Healthcare worth $21M as of Q2 2026.
- Marshall Wace bought 107,281 Tenet Healthcare shares in Q2 2026, an estimated $19.7M.
- Tenet Healthcare made up 0.02% of Marshall Wace's portfolio in Q2 2026, its #711 holding.
- Marshall Wace first reported a position in Tenet Healthcare in Q2 2015 and has held it in 26 quarters since.
- Marshall Wace's Tenet Healthcare position peaked at $186M in Q2 2023.
- 680 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.